Also known as N-butyl-1-deoxynojirimycin, NB-DNJ, Zavesca®, SC-48334, n-Butyl deoxynojirimycin, N-Butylmoranoline, N-(n-Butyl)deoxynojirimycin, Butyldeoxynojirimycin
Miglustat, sold under the brand name Zavesca among others, is a medication used to treat type I Gaucher disease and Pompe disease.
~5 min read
Miglustat, sold under the brand name Zavesca among others, is a medication used to treat type I Gaucher disease and Pompe disease.
It was approved for medical use in the European Union in November 2002, and for medical use in the United States in July 2003.
via Wikipedia infobox
via PubMed
via Wikidata sitelinks · CC0
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).